Oversea-Chinese Banking Corp (OCBC)’s ResMed RMD Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.94M	Sell	35,373 -496	-1%	-$124K	0.21%	93
2025 Q4	$8.64M	Sell	35,869 -7,795	-18%	-$1.99M	0.23%	75
2025 Q3	$12M	Buy	43,664 +301	+0.7%	+$82.2K	0.29%	69
2025 Q2	$11.2M	Sell	43,363 -11,132	-20%	-$2.66M	0.31%	64
2025 Q1	$12.1M	Buy	54,495 +7,911	+17%	+$1.85M	0.34%	63
2024 Q4	$10.7M	Buy	46,584 +27,132	+139%	+$6.53M	0.3%	69
2024 Q3	$4.75M	Buy	19,452 +2,891	+17%	+$646K	0.13%	121
2024 Q2	$3.17M	Buy	16,561 +1,011	+7%	+$205K	0.09%	140
2024 Q1	$3.08M	Buy	15,550 +919	+6%	+$168K	0.09%	149
2023 Q4	$2.52M	Buy	14,631 +1,250	+9%	+$192K	0.09%	134
2023 Q3	$1.98M	Buy	13,381 +524	+4%	+$94.7K	0.09%	145
2023 Q2	$2.81M	Buy	12,857 +836	+7%	+$186K	0.13%	123
2023 Q1	$2.63M	Buy	12,021 +280	+2%	+$60.7K	0.13%	112
2022 Q4	$2.44M	Buy	+11,741	New	+$2.58M	0.14%	112

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s RMD Position: Q1 2026 in Review

Oversea-Chinese Banking Corp (OCBC) reduced its ResMed (RMD) stake by 1.4% in Q1 2026, selling an estimated $124K and leaving 35,373 shares worth $7.94M. The position accounts for 0.21% of the portfolio, ranked #93.

Oversea-Chinese Banking Corp (OCBC) first reported a position in RMD in Q4 2022 and has held it in 14 quarters since. The position peaked at $12.1M in Q1 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Oversea-Chinese Banking Corp (OCBC) held 35,373 shares of ResMed worth $7.94M as of Q1 2026.
Oversea-Chinese Banking Corp (OCBC) sold 496 ResMed shares in Q1 2026, an estimated $124K.
ResMed made up 0.21% of Oversea-Chinese Banking Corp (OCBC)'s portfolio in Q1 2026, its #93 holding.
Oversea-Chinese Banking Corp (OCBC) first reported a position in ResMed in Q4 2022 and has held it in 14 quarters since.
Oversea-Chinese Banking Corp (OCBC)'s ResMed position peaked at $12.1M in Q1 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q1 2026, filed 28 Apr 2026.